A Phase 1/2/3, Placebo-Controlled, Randomized, Observer-Blind, Dose-Finding Study to Evaluate the Safety, Tolerability, Immunogenicity and Efficacy of SARS-COV2 Vaccine Candidates Against COVID-19 in Healthy Individuals